Larvol Delta - Phase-2-study-of-AVGBM1-a-tumorinitiating-cell-targeted-dendritic-cell-vaccine-in-newly-diagnosed-Glioblastoma-patients-safety-and-efficacy-assessment

AV-GBM-1 - AiVita Biomedical

temozolomide - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/36517865

Dec 16, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next